BIOMARKER CEREBLON FOR DIAGNOSING HEPATOCELLULAR CARCINOMA, AND NOVEL MONOCLONAL ANTIBODY SPECIFIC THERETO

The present invention relates to a use of Cereblon (CRBN) as a biomarker for diagnosing hepatocellular carcinoma, and a novel monoclonal antibody specific to Cereblon. More specifically, the present invention relates to a composition for diagnosing hepatocellular carcinoma or predicting a prognosis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HWANG, Sin, LEE, Kyung Jin
Format: Patent
Sprache:eng ; fre ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!